Angola expects 12 million COVID-19 vaccines in partnership with COVAX

A medical syringe and a vial in front of the COVAX word are seen in this creative illustrative photo. More than one hundred fifty COVID-19 coronavirus vaccine are in development across the world, several of which have the third phase of clinical trials, as media reported. (Photo illustration by STR/NurPhoto via Getty Images)

Angola expects to receive five million COVID-19 vaccines in February 2021 and the remaining seven million others in April in partnership with COVAX, the country’s Health Minister Silvia Lutucuta said Thursday.

Lutucuta said that conditions for the reception and conservation of the vaccines from Pfizer are already being created, adding that the vaccination priority will be given to people at risk, such as health professionals, the elderly, patients with diabetes, obesity, cancer, and kidney disease, and people living with HIV/AIDS.

Besides Pfizer’s vaccines, the minister said, the country may also acquire other vaccines that were certified and authorized by competent health agencies.

As it is a public health issue, the vaccination against COVID-19 will be conducted under the entire responsibility of the Ministry of Health and will be given in the health units previously defined by the national health authorities, Lutucuta said.

The World Health Organization (WHO) representative in Angola, Djamila Khady Cabral, said earlier that the COVAX intends to facilitate access to two billion vaccines against COVID-19, to cover 20 percent of the African population by 2021.

According to the WHO representative, the COVAX’s goal is to ensure that all countries have equal access to vaccines, so they are working at that time to raise the necessary funds to donate the vaccines to the poorest countries.

Angola has so far reported 15,925 positive cases, 362 deaths, and 8,679 recoveries.